Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Erja-Leena Paukkeri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Effect of remdesivir post hospitalization for COVID-19 infection from the randomized SOLIDARITY Finland trial
Solidarity Finland Investigators, Nevalainen, O. P. O., Horstia, S., Laakkonen, S., Rutanen, J., Mustonen, J. M. J., Kalliala, I. E. J., Ansakorpi, H., Kreivi, H. R., Kuutti, P., Paajanen, J., Parkkila, S., Paukkeri, E. L., Perola, M., Pourjamal, N., Renner, A., Rosberg, T., Rutanen, T., Savolainen, J., Haukka, J. K., & 2 others, Oct 2022, In: Nature Communications. 13, 6 p., 6152.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile5 Downloads (Pure) -
Remdesiviiri sairaalahoitoisessa COVID-19-taudissa: pragmaattinen, adaptiivinen, satunnaistettu Solidarity Finland -monikeskustutkimus
Rutanen, J., Nevalainen, O. P. O., Horstia, S., Laakkonen, S., Mustonen, J., Kilpeläinen, T. P., Ekroos, H., Järventie, J., Järvinen, P., Kalliala, I., Kauma, H., Kreivi, H-R., Kuitunen, I., Mattila, T., Myllärniemi, M., Mäntylä, J., Nykänen, T., Nystén, C., Paajanen, J., Paukkeri, E-L., & 7 others, 18 Aug 2022, In: Suomen Lääkärilehti. 77, 35-36, e32811.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile3 Downloads (Pure) -
MKP-1 promotes anti-inflammatory M(IL-4/IL-13) macrophage phenotype and mediates the anti-inflammatory effects of glucocorticoids
Pemmari, A., Paukkeri, E-L., Hämäläinen, M., Leppänen, T., Korhonen, R. & Moilanen, E., 2019, In: Basic and Clinical Pharmacology and Toxicology. 124, 4, p. 404-415Research output: Contribution to journal › Article › Scientific › peer-review
6 Citations (Scopus) -
Attenuating Effects of Nortrachelogenin on IL-4 and IL-13 Induced Alternative Macrophage Activation and on Bleomycin-Induced Dermal Fibrosis
Pemmari, A., Leppänen, T., Paukkeri, E-L., Scotece, M., Hämäläinen, M. & Moilanen, E., 2018, In: Journal of Agricultural and Food Chemistry. 66, 51, p. 13405-13413Research output: Contribution to journal › Article › Scientific › peer-review
1 Citation (Scopus) -
Gene expression in adverse reaction to metal debris around metal-on-metal arthroplasty: An RNA-Seq-based study
Pemmari, A., Leppänen, T., Paukkeri, E-L., Eskelinen, A., Moilanen, T. & Moilanen, E., 2018, In: JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY. 48, p. 149-156Research output: Contribution to journal › Article › Scientific › peer-review
3 Citations (Scopus)
Activities
- 30 Conference presentation
-
PPARalpha agonist fenofibrate and PPARγ agonist GW1929 differently regulate classical and alternative activation pathways in macrophages
Erja-Leena Paukkeri (Contributor), Eeva Moilanen (Contributor) & Antti Pemmari (Contributor)
11 Feb 2014Activity: Talk or presentation › Conference presentation
-
PPARalpha agonist fenofibrate and PPARγ agonist GW1929 differently regulate classical and alternative activation pathways in macrophages
Erja-Leena Paukkeri (Speaker), Eeva Moilanen (Speaker) & Antti Pemmari (Speaker)
23 Jan 2014Activity: Talk or presentation › Conference presentation
-
Effects of biodegradable polylactic acid fibers and dexamethasone on classical and alternative activation pathways in macrophages
Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor), Erja-Leena Paukkeri (Contributor), Antti Pemmari (Contributor) & Teuvo Tammela (Contributor)
23 Aug 2013Activity: Talk or presentation › Conference presentation
-
Inflammatory phenotype in peri-implant tissue associates with blood metal concentrations in patents with failed metal-on-metal hip prostheses
E-L Paukkeri (Contributor), R Korhonen (Contributor), A Eskelinen (Contributor), M Pesu (Contributor), E Moilanen (Contributor) & T Moilanen (Contributor)
20 Apr 2013Activity: Talk or presentation › Conference presentation
-
PPARalpha agonist fenofibrate and PPARgamma agonist GW1929 differently regulate classical and alternative activation pathways in macrophages
Antti Pemmari (Contributor), Eeva Moilanen (Contributor) & Erja-Leena Paukkeri (Contributor)
21 Mar 2013Activity: Talk or presentation › Conference presentation